the Observance of Emergency Exit Treatments During the Stay of Care at the Exit of Reims Emergencies

March 1, 2021 updated by: CHU de Reims

Multicentric Prospective Study of the Observance of Outpatient Treatments in Reims During the Care Continuum

The investigators would like to include patients consulting in a Accident and Emergency Department (AED) during the permanence of care the week of March 11 to 17, 2018. The data collection would concern socio-demographic data, their consultation to the AED, the follow-up given to the consultation and would take place by telephone contact of patients within 48 hours of the consultation.

why patients come to the emergency room, what are they waiting for? what are their main motivations? what do they do in emergencies, do they follow the treatments and recommendations?

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Study of the observance of emergency exit treatments during the permanence of care. This is a descriptive study with a prospective data collection that does not alter the management of the patient. The study is epidemiological, cross-sectional, prospective inclusion.

The investigators would like to include patients consulting in a AED during the permanence of care the week of March 11 to 17, 2018. The data collection would concern socio-demographic data, their consultation to the AED, the follow-up given to the consultation and would take place by telephone contact of patients within 48 hours of the consultation.

The objective is to study the follow-up given by the consultation to the emergencies, in terms of compliance, follow-up of the recommendations, the objective sought by the patient coming to the emergency department.

Understand the motivation of the consultation and why the treatment was not followed where appropriate.

Is there a sociodemographic explanation or is it the health network that results in the saturation of emergency services? Does the system still meet the expectations of people using it?

Study Type

Observational

Enrollment (Actual)

274

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Reims, France, 51092
        • CHU Reims

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

the group studied only concern adults consulting in the emergency and leaving after their consultations, durning the permanence of care

Description

Inclusion Criteria:

  • adults
  • consultation during the early stages of care
  • leaving after consultation
  • agrees to participate in the study

Exclusion Criteria:

  • minor patients
  • permanently off care
  • hospitalized patients
  • refusal to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
patient coming to the emergency department
the group studied only concern adult adults consulting in the emergency departments and leaving after their consultations, during the permanence of care
Behavioral: adherence to treatment of patients coming out of emergencies
Phone contact of patients within 48 hours of the consultation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
adherence to treatment
Time Frame: 2 days
Number of Participants who visited of the drugstore after emergency visit
2 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

CHU de Reims

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 11, 2019

Primary Completion (Actual)

March 18, 2019

Study Completion (Actual)

March 31, 2019

Study Registration Dates

First Submitted

February 7, 2019

First Submitted That Met QC Criteria

February 8, 2019

First Posted (Actual)

February 11, 2019

Study Record Updates

Last Update Posted (Actual)

March 2, 2021

Last Update Submitted That Met QC Criteria

March 1, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PO18168

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patient Coming to the Emergency Department for Any Reason

Clinical Trials on adherence to treatment of patients coming out of emergencies

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe